The 6th Gene Therapy Analytical Development Summit Europe is the premier event for tackling the most pressing challenges in gene therapy analytics. New for 2025, the summit introduces QC Readiness Workshops covering assay timing, ICH Q14 integration, and viral vector consistency, alongside in-depth discussions on optimising assay development, managing viral vector contamination, and enhancing AAV vector stability. Attendees will also explore next-gen analytical tools, strategies for scaling production while maintaining quality, and overcoming tech transfer hurdles. Industry leaders will gather to navigate evolving regulatory landscapes, mitigate risks, and optimise manufacturing efficiency, ensuring compliance and consistency in gene therapy development. Don’t miss this essential event!
Join the Analytical Frontier for Gene Therapies this May to:
Gain in-depth knowledge of cutting-edge methods like Next Generation Sequencing (NGS), ddPCR, and mass spectrometry from experts at UCB, SGS, Quatre Lab and Intertek to improve robustness, scalability, cost-efficiency, and regulatory compliance.
Take home actionable guidance on assay development and optimisation from Johnson & Johnson, Aviado Bio and GenSight Bio and hear from the MHRA on harmonising standards for gene therapy development to align your regulatory requirements and ensure clinical relevance.
Enjoy 8+ hours of dedicated networking with top industry pioneers and hear success stories from Purespring Therapeutics, Orchard Therapeutics, Sarpeta and more.
Find solutions for scalability, technology transfer hurdles, CMC alignment and late-stage changes with insights from KU Leuven, GenSight Bio, Sparing Vision, Spur Therapeutics, British Pharmacopoeia and more.
Who Will You Meet?
The 6th Gene Therapy Analytical Development Summit Europe is the only industry-focused event tailored for a European audience. It brings together biotech and pharma companies, leading analytical technology providers, and experts across analytical development, quality control, CMC, technology, and regulatory fields.
